Nifedipine GITS and Amlodipine Besylate on Recovery of Blood Pressure Rhythm and Arterial Stiffness (NARRAS)
A Comparative Study for the Effects of Nifedipine GITS and Amlodipine Besylate on Recovery of Blood Pressure Rhythm and Arterial Stiffness in the Young and Middle-aged Subjects With Non-dipper Hypertension
Sponsor: Bayer
Terminated
The patient recruitment and follow-ups were influenced with the pandemic of COVID-19
Listed as NCT02940548, this PHASE4 trial focuses on Hypertension and remains terminated or withdrawn. Sponsored by Bayer, it has been updated 7 times since 2016, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
May 2022 — Jul 2024 [monthly]
Terminated PHASE4
Status: Unknown Status → Terminated
-
Jan 2021 — May 2022 [monthly]
Unknown Status PHASE4
-
Jan 2019 — Jan 2021 [monthly]
Unknown Status PHASE4
Status: Recruiting → Unknown Status
▶ Show 2 earlier versions
-
Jun 2018 — Jan 2019 [monthly]
Recruiting PHASE4
-
Jan 2017 — Jun 2018 [monthly]
Recruiting PHASE4
First recorded
Dec 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Bayer
- Jing Liu
For direct contact, visit the study record on ClinicalTrials.gov .